A new type of medication can lead to an improvement in the aortic valve narrowing. Treatment based on raising high-density lipoproteins (HDL), the so-called good cholesterol level in patients suffering from aortic valve stenosis, could potentially transform the treatment approach of this disease, notably by avoiding open heart surgery. After only 14 days of treatment animals with aortic valve narrowing had returned almost to normal.